Citation: L. Adorini et S. Trembleau, IMMUNE DEVIATION TOWARDS TH2 INHIBITS TH-1-MEDIATED AUTOIMMUNE DIABETES, Biochemical Society transactions, 25(2), 1997, pp. 625-629
Authors:
HARRISON LC
HONEYMAN MC
TREMBLEAU S
GREGORI S
GALLAZZI F
AUGSTEIN P
BRUSIC V
HAMMER J
ADORINI L
Citation: Lc. Harrison et al., A PEPTIDE-BINDING MOTIF FOR I-A(G7), THE CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) MOLECULE OF NOD AND BIOZZI AB H MICE/, The Journal of experimental medicine, 185(6), 1997, pp. 1013-1021
Authors:
TREMBLEAU S
PENNA G
GREGORI S
GATELY MK
ADORINI L
Citation: S. Trembleau et al., DEVIATION OF PANCREAS-INFILTRATING CELLS TO TH2 BY INTERLEUKIN-12 ANTAGONIST ADMINISTRATION INHIBITS AUTOIMMUNE DIABETES, European Journal of Immunology, 27(9), 1997, pp. 2330-2339
Citation: L. Adorini et al., MANIPULATION OF THE TH1 TH2 CELL BALANCE - AN APPROACH TO TREAT HUMANAUTOIMMUNE-DISEASES/, Autoimmunity, 23(1), 1996, pp. 53-68
Authors:
TREMBLEAU S
GIACOMINI P
GUERY JC
SETINI A
HAMMER J
SETTE A
APPELLA E
ADORINI L
Citation: S. Trembleau et al., DR-ALPHA-EP HETERODIMERS IN DRA TRANSGENIC MICE HINDER EXPRESSION OF E-ALPHA-EP MOLECULES AND ARE MORE EFFICIENT IN ANTIGEN PRESENTATION, International immunology, 7(12), 1995, pp. 1927-1938
Citation: S. Trembleau et L. Adorini, ROLE OF IL-12 IN THE INDUCTION OF INSULIN-DEPENDENT DIABETES-MELLITUS, Journal of cellular biochemistry, 1995, pp. 179-179
Authors:
TREMBLEAU S
PENNA G
BOSI E
MORTARA A
GATELY MK
ADORINI L
Citation: S. Trembleau et al., INTERLEUKIN-12 ADMINISTRATION INDUCES T-HELPER TYPE-1 CELLS AND ACCELERATES AUTOIMMUNE DIABETES IN NOD MICE, The Journal of experimental medicine, 181(2), 1995, pp. 817-821
Authors:
GILFILLAN S
BACHMANN M
TREMBLEAU S
ADORINI L
KALINKE U
ZINKERNAGEL R
BENOIST C
MATHIS D
Citation: S. Gilfillan et al., EFFICIENT IMMUNE-RESPONSES IN MICE LACKING N-REGION DIVERSITY, European Journal of Immunology, 25(11), 1995, pp. 3115-3122
Authors:
DENG HK
APPLE R
CLARESALZLER M
TREMBLEAU S
MATHIS D
ADORINI L
SERCARZ E
Citation: Hk. Deng et al., DETERMINANT CAPTURE AS A POSSIBLE MECHANISM OF PROTECTION AFFORDED BYMAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES IN AUTOIMMUNE-DISEASE, The Journal of experimental medicine, 178(5), 1993, pp. 1675-1680